Reply to “comment on: laparoscopic roux-en-y fistulojejunostomy as a salvage procedure in patients with chronic gastric leak after sleeve gastrectomy”
We read with great interest the comment by Smith BR [1] regarding our recently published study “Laparoscopic Roux-en-Y fistulojejunostomy as a salvage procedure in patients with chronic gastric leak after sleeve gastrectomy” [2]. We appreciate the author’s interest in our study and would like to thank him for his comments and for stressing out the importance of the reported results. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 26, 2023 Category: Surgery Authors: Panagiotis LAINAS, Evangelia TRIANTAFYLLOU, Ibrahim DAGHER, Jean GUGENHEIM, Imed BEN. AMOR Tags: Letter to the Editor Source Type: research

The Role of Obesity Severity in Minnesota Multiphasic Personality Inventory-2-Restructured Form Prediction of 12-Month Bariatric Surgery Outcomes
The Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF) has been widely used in bariatric surgery samples. However, questions remain regarding its utility when predicting changes in body mass index over time following bariatric surgery. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 26, 2023 Category: Surgery Authors: Tim Hoyt, Fawn A. Walter, Tegan M. Michl Tags: Original articles Source Type: research

Racial differences after bariatric surgery: 24-month follow-up of a randomized, controlled trial for postoperative loss-of-control eating
This prospective study examined and extended initial short-term findings regarding racial differences in post –bariatric surgery loss-of-control (LOC) eating and weight loss to longer-term outcomes through 24-month follow-ups. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 25, 2023 Category: Surgery Authors: Valentina Ivezaj, Abhaya Dilip, Andrew J. Duffy, Carlos M. Grilo Tags: Original article Source Type: research

ASMBS Statement on Metabolic and Bariatric Surgery for Beneficiaries of Centers for Medicare and Medicaid Services (CMS) with a Review of the Literature
Metabolic and Bariatric surgery (MBS) was first offered to the public in the 1960s. The introduction of laparoscopy in the late 1990 ’s revolutionized the field with a significant increase in the number of MBS procedures. The rapid growth of MBS led to more scrutiny regarding the outcomes of MBS especially in CMS Medicare beneficiaries.1-3 In November 2005, the Centers for Medicare& Medicaid services (CMS) considered a proposal to end coverage for MBS for Medicare beneficiaries>65 years of age due to safety concerns and increased surgical risk. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 25, 2023 Category: Surgery Authors: Abdelrahman Nimeri, Rodolfo Oviedo, Wesley R. Vosburg, John Fam, Cynthia A. Blalock, Maria S. Altieri, Toms Augustin, Peter Hallowell, Jonathan T. Carter, for the Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery Tags: ASMBS Guidelines/Statements Source Type: research

Racial Differences After Bariatric Surgery: 24-Month Follow-up of a Randomized Controlled Trial for Post-operative Loss-of-Control Eating
This prospective study examined and extended initial short-term findings regarding racial differences in post-bariatric surgery loss-of-control (LOC)-eating and weight-loss to longer-term outcomes through 24-month follow-ups. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 25, 2023 Category: Surgery Authors: Valentina Ivezaj, Abhaya Dilip, Andrew J. Duffy, Carlos M. Grilo Tags: Original articles Source Type: research

Comment on: Bariatric surgery protects against Barrett ’s esophagus and esophageal adenocarcinoma: a national database study
I appreciate the opportunity to comment on the article titled, “Bariatric surgery protects against Barrett’s esophagus and esophageal adenocarcinoma: a national database study,” by Hurtado et al. [1]. I congratulate the authors for their interest in analyzing and discussing this topic and for the enormous effort that this study demands. The authors concl ude that bariatric surgery decreases the risk of developing gastroesophageal reflux disease (GERD) and Barrett esophagus (BE). It is known that patients with obesity have more severe esophagitis and BE than average patients and that sleeve gastrectomy (SG) and lapar...
Source: Surgery for Obesity and Related Diseases - September 24, 2023 Category: Surgery Authors: Italo Braghetto Tags: Editorial comment Source Type: research

Comment on: Bariatric Surgery protects against Barrett's Esophagus: A National Database Study
I appreciate the opportunity to comment on the paper "Bariatric Surgery protects against Barrett's Esophagus: A National Database Study". (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 24, 2023 Category: Surgery Authors: Italo Braghetto Tags: Editorial Source Type: research

Comment on: Insulin resistance levels predicted metabolic improvement and weight loss after metabolic surgery in Chinese patients with type 2 diabetes
This study revealed that insulin resistance levels were predictive of metabolic impr ovement and weight loss 1 year after metabolic surgery in Chinese patients diagnosed with type 2 diabetes exhibiting a body mass index range of 25–32.5 kg/m2. We wish to provide some observations on the present status of this procedure in Latin American nations with a specific focus on Colombia. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 23, 2023 Category: Surgery Authors: Gonzalo Andr és Domínguez Alvarado, Jeanne Stephanie García Murillo, Lizette Paola Zambrano Silva, Luis Ernesto López Gómez Tags: Letter to the editor Source Type: research

Comment on: “Insulin resistance levels predicted metabolic improvement and weight loss after metabolic surgery in Chinese patients with type 2 diabetes.”
This study revealed that insulin resistance levels were predictive of metabolic improvement and weight loss one year post metabolic surgery (MS) in Chinese patients diagnosed with type 2 diabetes, exhibiting a BMI range of 25-32.5 kg/m. We wish to provide some observations on the present status of this procedure in Latin American nations, with a specific focus on Colombia. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 23, 2023 Category: Surgery Authors: Gonzalo Andr és Domínguez Alvarado, Jeanne Stephanie García Murillo, Lizette Paola Zambrano Silva, Luis Ernesto López Gómez Tags: Letter to the Editor Source Type: research

Cartoon
(Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 16, 2023 Category: Surgery Tags: Cartoon Source Type: research

SOARD Category 1 CME Credit Featured Articles, Volume 19, October 2023
Matthew Aizpuru, Amy E. Glasgow, Marita Salame, Omer Ul Hassan, Maria L. Collazo-Clavell, Todd A. Kellogg, Elizabeth B. Habermann, Karen Grothe, Omar M. Ghanem (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 16, 2023 Category: Surgery Tags: Continuing medical education program Source Type: research

Editorial Board
(Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 16, 2023 Category: Surgery Source Type: research

Table of Contents
(Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 16, 2023 Category: Surgery Source Type: research

Endoscopic sleeve gastroplasty and its role in the treatment of obesity: a  systematic review
Obesity rates nearly tripled from 1975 to 2016 across the globe [1]. As obesity rates have increased, so have obesity-related co-morbidities such as cardiovascular disease, diabetes, hypertension, hyperlipidemia, obstructive sleep apnea, liver and kidney disease, and cancer [2 –4]. To date, metabolic and bariatric surgery (MBS) remains the most effective treatment modality for patients with severe obesity [5], with laparoscopic sleeve gastrectomy (LSG) being the most prevalent bariatric procedure performed worldwide [6]. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 15, 2023 Category: Surgery Authors: Salvatore Docimo, Laura Aylward, Vance L. Albaugh, Cheguevara Afaneh, Sofiane El Djouzi, Mohamed Ali, Maria S. Altieri, Jonathan Carter, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee Tags: ASMBS Guidelines/statements Source Type: research

Endoscopic Sleeve Gastroplasty and its Role in the Treatment of Obesity: A Systematic Review
The majority of peer-reviewed studies reported the use of ESG for patients with body mass index of 30-40 kg/m2. There were sparse outcome data for patients with body mass index>40 or (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 15, 2023 Category: Surgery Authors: Salvatore Docimo, Laura Aylward, Vance L. Albaugh, Cheguevara Afaneh, Sofiane El Djouzi, Mohamed Ali, Maria S. Altieri, Jonathan Carter, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee Tags: ASMBS Guidelines/Statements Source Type: research